Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy

Aclaris Therapeutics Shares Outstanding 2014-2018 | ACRS

Aclaris Therapeutics shares outstanding from 2014 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Aclaris Therapeutics Annual Shares Outstanding
(Millions of Shares)
2017 28
2016 21
2015 6
2014 2
2013 1
Aclaris Therapeutics Quarterly Shares Outstanding
(Millions of Shares)
Q3 2018 31
Q2 2018 31
Q1 2018 31
Q4 2017 28
Q3 2017 29
Q2 2017 27
Q1 2017 26
Q4 2016 21
Q3 2016 21
Q2 2016 21
Q1 2016 20
Q4 2015 6
Q3 2015 2
Q2 2015 2
Q1 2015 2
Q4 2014 0
Q3 2014 2
Q4 2013 0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.285B $0.010B
Aclaris Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing drugs to met needs in dermatology. Its drug candidate consists of A-101, a high-concentration hydrogen peroxide topical solution which is being developed as a prescription treatment for seborrheic keratosis a common non-malignant skin tumor and A-102, a proprietary topical gel dosage form of hydrogen peroxide for the treatment of SK and common warts which are in different clinical trial. Aclaris Therapeutics, Inc. is headquartered in Malvern, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $47.264B 31.44
Takeda Pharmaceutical (TAK) Japan $33.216B 12.29
Grifols (GRFS) Spain $13.242B 16.05
Ionis Pharmaceuticals (IONS) United States $11.018B 34.17
Neurocrine Biosciences (NBIX) United States $7.958B 515.41
Jazz Pharmaceuticals (JAZZ) Ireland $7.734B 11.07
Sage Therapeutics (SAGE) United States $7.351B 0.00
Tilray (TLRY) United States $6.502B 0.00
Catalent (CTLT) United States $6.214B 26.02
Nektar Therapeutics (NKTR) United States $5.991B 9.56
United Therapeutics (UTHR) United States $5.188B 8.82
FibroGen (FGEN) United States $4.806B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $4.304B 22.87
Taro Pharmaceutical Industries (TARO) Israel $4.234B 13.63
Portola Pharmaceuticals (PTLA) United States $2.233B 0.00
Zogenix (ZGNX) United States $2.222B 0.00
Madrigal Pharmaceuticals (MDGL) United States $2.218B 0.00
PTC Therapeutics (PTCT) United States $2.176B 0.00
USANA Health Sciences (USNA) United States $2.131B 17.89
Ironwood Pharmaceuticals (IRWD) United States $2.108B 0.00
Aerie Pharmaceuticals (AERI) United States $2.075B 0.00
Enanta Pharmaceuticals (ENTA) United States $2.017B 25.13
Endo (ENDP) Ireland $1.968B 3.03
Heron Therapeutics (HRTX) United States $1.924B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.774B 0.00
Xencor (XNCR) United States $1.704B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.681B 145.64
Corcept Therapeutics (CORT) United States $1.401B 20.35
TherapeuticsMD (TXMD) United States $1.336B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.334B 0.00
Esperion Therapeutics (ESPR) United States $1.179B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.122B 0.00
Tricida (TCDA) United States $1.077B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.869B 0.00
Radius Health (RDUS) United States $0.854B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.609B 0.00
Dermira (DERM) United States $0.598B 0.00
Odonate Therapeutics (ODT) United States $0.589B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.587B 0.00
Collegium Pharmaceutical (COLL) United States $0.579B 0.00
ChemoCentryx (CCXI) United States $0.577B 0.00
Forty Seven (FTSV) United States $0.571B 0.00
GlycoMimetics (GLYC) United States $0.546B 0.00
ArQule (ARQL) United States $0.524B 0.00
KalVista Pharmaceuticals (KALV) United States $0.487B 0.00
Siga Technologies (SIGA) United States $0.486B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.485B 28.62
Corbus Pharmaceuticals Holdings (CRBP) United States $0.481B 0.00
Akebia Therapeutics (AKBA) United States $0.462B 0.00
Flexion Therapeutics (FLXN) United States $0.462B 0.00
Translate Bio (TBIO) United States $0.453B 0.00
TCR2 THERAPTCS (TCRR) United States $0.439B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.428B 0.00
Concert Pharmaceuticals (CNCE) United States $0.394B 0.00
OptiNose (OPTN) United States $0.388B 0.00
ImmunoGen (IMGN) United States $0.378B 0.00
Aptorum Group (APM) China $0.378B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.358B 0.00
Minerva Neurosciences (NERV) United States $0.329B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.329B 0.00
Karyopharm Therapeutics (KPTI) United States $0.326B 0.00
Lannett Co Inc (LCI) United States $0.317B 2.94
CASI Pharmaceuticals (CASI) United States $0.315B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.303B 11.24
HARPOON THERAPT (HARP) United States $0.290B 0.00
Mast Therapeutics (SVRA) United States $0.284B 0.00
Immune Design (IMDZ) United States $0.283B 0.00
Xeris Pharmaceuticals (XERS) United States $0.282B 0.00
Majesco Entertainment (PTE) United States $0.271B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.269B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.263B 0.00
Affimed (AFMD) Germany $0.261B 0.00
Dova Pharmaceuticals (DOVA) United States $0.261B 0.00
Calithera Biosciences (CALA) United States $0.252B 0.00
ElectroCore (ECOR) United States $0.237B 0.00
Opexa Therapeutics (ACER) United States $0.237B 0.00
Tyme Technologies (TYME) United States $0.237B 0.00
Galectin Therapeutics (GALT) United States $0.228B 0.00
Jounce Therapeutics (JNCE) United States $0.226B 0.00
Aldeyra Therapeutics (ALDX) United States $0.219B 0.00
MEI Pharma (MEIP) United States $0.218B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.207B 0.00
Ardelyx (ARDX) United States $0.205B 0.00
IMV INC (IMV) Canada $0.204B 0.00
Molecular Templates (MTEM) United States $0.202B 0.00
Recro Pharma (REPH) United States $0.200B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.200B 0.00
Nature's Sunshine Products (NATR) United States $0.195B 202.00
Aratana Therapeutics (PETX) United States $0.191B 0.00
Redhill Biopharma (RDHL) Israel $0.187B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.184B 0.00
Rafael Holdings (RFL) United States $0.176B 0.00
Ocular Therapeutix (OCUL) United States $0.176B 0.00
Aquestive Therapeutics (AQST) United States $0.174B 0.00
Neon Therapeutics (NTGN) United States $0.167B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.160B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.158B 0.00
China SXT Pharmaceuticals (SXTC) China $0.144B 0.00
ProNAi Therapeutics (SRRA) Canada $0.143B 0.00
AgeX Therapeutics (AGE) United States $0.142B 0.00
Cardiome Pharma (CORV) Canada $0.142B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.141B 0.00
MediWound (MDWD) Israel $0.141B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.140B 0.00
Champions Oncology (CSBR) United States $0.129B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.128B 0.00
DURECT (DRRX) United States $0.121B 0.00
Zafgen (ZFGN) United States $0.111B 0.00
Adherex Technologies (FENC) United States $0.110B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.109B 0.00
Infinity Pharmaceuticals (INFI) United States $0.102B 0.00
Iterum Therapeutics (ITRM) Ireland $0.096B 0.00
Nivalis Therapeutics (ALPN) United States $0.095B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.092B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.091B 0.00
Otonomy (OTIC) United States $0.091B 0.00
SCYNEXIS (SCYX) United States $0.087B 0.00
Neos Therapeutics (NEOS) United States $0.087B 0.00
India Globalization Capital (IGC) United States $0.086B 0.00
Natural Alternatives (NAII) United States $0.084B 8.20
Genocea Biosciences (GNCA) United States $0.081B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.074B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.073B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.069B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.067B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.061B 0.00
Avenue Therapeutics (ATXI) United States $0.059B 0.00
CTI BioPharma (CTIC) United States $0.059B 0.00
Forward Pharma (FWP) Denmark $0.058B 0.00
KemPharm (KMPH) United States $0.056B 0.00
Melinta Therapeutics (MLNT) United States $0.053B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.052B 0.00
Lipocine (LPCN) United States $0.052B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.050B 0.00
Capnia (SLNO) United States $0.049B 0.00
BioLineRx (BLRX) Israel $0.047B 0.00
Mannatechorporated (MTEX) United States $0.042B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.040B 0.00
ProPhase Labs (PRPH) United States $0.039B 0.00
NOVAN INC (NOVN) United States $0.034B 0.00
HANCOCK JAFFE (HJLI) United States $0.034B 0.00
Achaogen (AKAO) United States $0.033B 0.00
PharmAthene (ALT) United States $0.030B 0.00
Heat Biologics (HTBX) United States $0.030B 0.00
ContraFect (CFRX) United States $0.029B 0.00
Shineco (TYHT) China $0.028B 4.69
Summit Therapeutics (SMMT) United Kingdom $0.027B 0.00
Citius Pharmaceuticals (CTXR) United States $0.027B 0.00
IsoRay (ISR) United States $0.025B 0.00
Can-Fite Biopharma (CANF) Israel $0.025B 0.00
Onconova Therapeutics (ONTX) United States $0.024B 0.00
Biomerica (BMRA) United States $0.023B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.023B 0.00
Jaguar Animal Health (JAGX) United States $0.023B 0.00
ESSA Pharma (EPIX) Canada $0.022B 0.00
Pain Therapeutics (PTIE) United States $0.022B 0.00
Achieve Life Sciences (ACHV) United States $0.021B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.020B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.019B 0.00
NanoViricides (NNVC) United States $0.019B 0.00
Xenetic Biosciences (XBIO) United States $0.019B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.018B 0.00
Bio-Path Holdings (BPTH) United States $0.017B 0.00
VAXART, INC (VXRT) United States $0.017B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.012B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.012B 0.00
PRECISION THERAPEUTICS INC (AIPT) United States $0.012B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.011B 0.00
Midatech Pharma (MTP) United Kingdom $0.011B 0.00
Regulus Therapeutics (RGLS) United States $0.010B 0.00
Trillium Therapeutics (TRIL) Canada $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.008B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.007B 0.00
Intellipharmaceutics (IPCI) Canada $0.006B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.006B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.004B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.000B 0.00
Bio Blast Pharma (ORPN) Israel $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00